{"AllianceGenome": "1008", "HGNC": "1008", "MIM": "602597", "_id": "607", "_version": 1, "accession": {"genomic": ["AC242628.1", "AL359207.7", "AL590667.7", "CH471223.1", "CP068277.2", "HI574316.1", "NC_000001.11", "NC_060925.1"], "protein": ["AAI16452.1", "CAA73942.1", "CAI15198.1", "CBX47647.1", "EAW50932.1", "EAW50933.1", "NP_004317.2", "O00512.4"], "rna": ["AW104430.1", "BC116451.1", "CN281037.1", "CN281038.1", "DA593760.1", "NM_004326.4", "Y13620.1"], "translation": [{"protein": "AAI16452.1", "rna": "BC116451.1"}, {"protein": "CAA73942.1", "rna": "Y13620.1"}, {"protein": "NP_004317.2", "rna": "NM_004326.4"}]}, "alias": "LGS", "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "limited", "classification_date": "2023-09-11T16:00:00.000Z", "disease_label": "congenital heart disease", "gcep": "Congenital Heart Disease Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0005453", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7f45b6e5-4286-40d2-aadf-9b15a62c26df-2023-09-11T160000.000Z", "sop": "SOP9"}}, "ensembl": {"gene": "ENSG00000116128", "protein": ["ENSP00000234739", "ENSP00000506908", "ENSP00000507238"], "transcript": ["ENST00000234739", "ENST00000497938", "ENST00000683836", "ENST00000684121"], "translation": [{"protein": "ENSP00000506908", "rna": "ENST00000683836"}, {"protein": "ENSP00000234739", "rna": "ENST00000234739"}, {"protein": "ENSP00000507238", "rna": "ENST00000684121"}], "type_of_gene": "protein_coding"}, "entrezgene": "607", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 27.59370339, "exp_mis": 483.2498875, "exp_syn": 191.9557, "lof_z": 4.26061363736823, "mis_z": -1.37394144820226, "mu_lof": 2.17648485909e-06, "mu_mis": 4.23925382071e-05, "mu_syn": 1.66830155914e-05, "n_lof": 5.0, "n_mis": 545.0, "n_syn": 237.0, "p_li": 0.831846216932657, "p_null": 1.23201255805031e-06, "p_rec": 0.168152551054785, "syn_z": -2.01552785216362}, "bp": 4281, "cds_end": 147096760, "cds_start": 147083635, "n_exons": 7, "nonpsych": {"exp_lof": 24.8305157, "exp_mis": 437.2433452, "exp_syn": 173.5940104, "lof_z": 4.30252164482247, "mis_z": -1.05546693757161, "mu_lof": 2.17648485909e-06, "mu_mis": 4.23925382071e-05, "mu_syn": 1.66830155914e-05, "n_lof": 3.0, "n_mis": 481.0, "n_syn": 211.0, "p_li": 0.981999803319491, "p_null": 1.25120919464566e-07, "p_rec": 0.0180000715595901, "syn_z": -1.78746440807017}, "nontcga": {"exp_lof": 25.37212859, "exp_mis": 444.57585, "exp_syn": 176.58519989, "lof_z": 3.9896902819036, "mis_z": -1.28596315968961, "mu_lof": 2.17648485909e-06, "mu_mis": 4.23925382071e-05, "mu_syn": 1.66830155914e-05, "n_lof": 5.0, "n_mis": 499.0, "n_syn": 216.0, "p_li": 0.69181985304176, "p_null": 7.00691443359451e-06, "p_rec": 0.308173140043806, "syn_z": -1.878038445833}, "transcript": "ENST00000234739.3"}, "exons": [{"cdsend": 147624959, "cdsstart": 147611836, "chr": "1", "position": [[147541500, 147541674], [147604776, 147604911], [147606783, 147606866], [147611577, 147611889], [147612882, 147613199], [147614426, 147614616], [147615802, 147615902], [147618815, 147621057], [147622270, 147622531], [147623841, 147626214]], "strand": 1, "transcript": "NM_004326", "txend": 147626214, "txstart": 147541500}], "exons_hg19": [{"cdsend": 147096760, "cdsstart": 147083635, "chr": "1", "position": [[147013270, 147013444], [147076569, 147076704], [147078576, 147078659], [147083376, 147083688], [147084681, 147084998], [147086225, 147086415], [147087602, 147087702], [147090621, 147092863], [147094071, 147094332], [147095642, 147098015]], "strand": 1, "transcript": "NM_004326", "txend": 147098015, "txstart": 147013270}], "generif": [{"pubmed": 17052462, "text": "crystallographic analysis of how beta-catenin, BCL9, BCL9-2 and Tcf4 interact"}, {"pubmed": 18347063, "text": "BCL9 itself contains a transcriptional activation domain in the C terminus, which functionally synergizes in lymphoid cells with the C-terminal transactivation domain of beta-catenin."}, {"pubmed": 18498752, "text": "Data show that human and Drosophila Pygo PHD fingers associate with their cognate HD1 domains from BCL9/Legless to bind specifically to the histone H3 tail methylated at lysine 4 (H3K4me)."}, {"pubmed": 18789482, "text": "Overexpression and altered subcellular localization of ATG16L1 protein in human oral squamous-cell carcinoma: correlation with lymphovascular invasion and lymph-node metastasis are reported."}, {"pubmed": 19715304, "text": "The amino-terminus of the BCL9 peptide is critical for maintaining the wild-type binding affinity of the BCL9 peptide to beta-catenin."}, {"pubmed": 19738061, "text": "Findings suggest that deregulation of BCL9 is an important contributing factor to tumor progression in multiple myeloma and colon neoplasms."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20637214, "text": "Pygo2 PHD is the only known PHD finger that is capable of interacting simultaneously with two functional ligands, B9L and BCL9"}, {"pubmed": 21383261, "text": "These findings indicate that common variations in the BCL9 gene confer risk of schizophrenia and may also be associated with bipolar disorder and major depressive disorder in the Chinese Han population."}, {"pubmed": 22024689, "text": "growth factor induced proliferation mediates a neutralizing response by significantly increasing miR-30c-2* which reduces BCL9 expression and cell proliferation in SKOV-3 and OVCAR-3 cells"}, {"pubmed": 22914623, "text": "Inhibition of the BCL9-beta-catenin interaction and selectively suppresses oncogenic Wnt transcription."}, {"pubmed": 23382809, "text": "we detected five SNPs in the first two genes/loci - BCL9 and C9orf5 - strongly associated with negative symptoms of schizophrenia"}, {"pubmed": 24419084, "text": "By beta-catenin's association with LEF1 and BCL9-2/B9L."}, {"pubmed": 24599134, "text": "MiR-30-5p downregulation occurs as a result of interaction between multiple myeloma cells and bone marrow stromal cells, which in turn enhances expression of BCL9."}, {"pubmed": 26081897, "text": "PCDH10 antagonized MM cell proliferation via the downregulation of Wnt/beta-catenin/BCL-9 signaling, whereas PCDH10 repressed the expression of AKT to promote the expression of GSK3beta and then to restrain the activation of beta-catenin"}, {"pubmed": 26384318, "text": "BCL9 is a molecular driver of DCIS invasive progression."}, {"pubmed": 26494551, "text": "findings indicate that BCL9 most likely does not harbor a common genetic variant that can increase the risk for schizophrenia in the Japanese population"}, {"pubmed": 26844272, "text": "BCL9/9L-beta-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer"}, {"pubmed": 27121066, "text": "results from this study demonstrated that hypoxia induced BCL-9 expression in human CRC cells mainly through HIF-1alpha, which could be an important underlying mechanism for increased BCL-9 expression in CRC."}, {"pubmed": 27314976, "text": "it was demonstrated that miR218 modulated a novel molecular target and the present study provided novel insights into potential mechanisms of RCC oncogenesis."}, {"pubmed": 27507882, "text": "MEF2D-BCL9-positive patients had B-cell precursor immunophenotype and were characterized as being older in age, being resistant to chemotherapy, having very early relapse, and having leukemic blasts that mimic morphologically mature B-cell leukemia with markedly high expression of HDAC9."}, {"pubmed": 28074862, "text": "Specific regulation of BCL9 expression by HIF-1alpha may prove to be an underlying crosstalk between Wnt/beta-catenin signaling and hypoxia signaling pathways."}, {"pubmed": 28296634, "text": "The authors used CRISPR/Cas9 genome engineering of Drosophila legless (lgs) and human BCL9 and B9L to show that the C-terminus downstream of their adaptor elements is crucial for Wnt responses."}, {"pubmed": 28769030, "text": "miR-30a acts as a tumor suppressor by double-targeting COX-2 and BCL9, and significantly affects the development of H. pylori-induced gastric cancer, shedding new light on the mechanisms underlying H. pylori-associated gastric cancer."}, {"pubmed": 29271667, "text": "SOX7 inhibits oncogenic beta-catenin-mediated transcription by disrupting the beta-catenin/BCL9 interaction."}, {"pubmed": 29428231, "text": "The gene BCL9 is overexpressed in malignant adrenocortical tumors and promotes clonal ACC cell growth. These findings suggest that BCL9 overexpression may serve as an alternative driver of constitutive Wnt/beta-Catenin activation in ACC and could represent a potential molecular and diagnostic marker of tumor malignancy."}, {"pubmed": 30009824, "text": "High BCL9 expression is associated with cisplatin-resistance in non-small cell lung cancer."}, {"pubmed": 30172867, "text": "Results find that BCL9 is upregulated in osteosarcoma (OS) tissues and promotes OS proliferation, migration and invasion. BCL9 is a downstream target of miR-1301 in OS cells. In addition, BCL9 restoration could reversed the functional effects of miR-1301 overexpression on OS cell proliferation, migration and invasion. These results revealed the important role of BCL9 in OS tumor progression."}, {"pubmed": 30217955, "text": "results revealed a novel role of BCL9 in controlling mitotic Wnt signalling to promote cell division and growth."}, {"pubmed": 30472057, "text": "We found that miR-532 was significantly upregulated in patients with intervertebral disc degeneration and plays a pro-apoptotic role in human intervertebral disc nucleus pulposus cells. Further, Bcl-9 was confirmed to be a direct target of miR-532 and might be a potential target for disc degeneration therapy."}, {"pubmed": 30909141, "text": "SNHG16 promotes BCL9 expression by sponging miR-1301 to facilitate the proliferation, migration and invasion of OS cells."}, {"pubmed": 31081087, "text": "MiR-30c exerts tumor suppressive functions in colorectal carcinoma by directly targeting BCL9."}, {"pubmed": 31088961, "text": "Investigated targeting the protein interactions of catenin beta 1 and B-cell lymphoma 9 protein (BCL9) binding using peptides designed by peptidomimetic drug design."}, {"pubmed": 31911584, "text": "In response to spontaneous calcium transients or cellular stress, BCL9 is recruited adjacent to the interchromosomal regions, where it stabilizes the mRNA of calcium signaling and neural associated genes by interacting with paraspeckle proteins."}, {"pubmed": 33767438, "text": "BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer."}, {"pubmed": 33838016, "text": "miR-140-3p inhibits colorectal cancer progression and its liver metastasis by targeting BCL9 and BCL2."}, {"pubmed": 33862557, "text": "Evidence for frequent concurrent DCUN1D1, FGFR1, BCL9 gene copy number amplification in squamous cell lung cancer."}, {"pubmed": 33974352, "text": "LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/beta-catenin signaling."}, {"pubmed": 34545187, "text": "The interactions of Bcl9/Bcl9L with beta-catenin and Pygopus promote breast cancer growth, invasion, and metastasis."}, {"pubmed": 35027586, "text": "Hypoxia-inducible factor 1alpha induces osteo/odontoblast differentiation of human dental pulp stem cells via Wnt/beta-catenin transcriptional cofactor BCL9."}, {"pubmed": 36803362, "text": "Prognostic and survival impact of BCL9 and RPS6KB1 copy number variation detected from circulating free DNA in hepatocellular carcinoma."}], "genomic_pos": {"chr": "1", "end": 147626216, "ensemblgene": "ENSG00000116128", "start": 147541501, "strand": 1}, "genomic_pos_hg19": [{"chr": "1", "end": 147098017, "start": 147013182, "strand": 1}, {"chr": "HG1287_PATCH", "end": 148312631, "start": 148227827, "strand": 1}], "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0006366", "qualifier": "involved_in", "term": "transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0014908", "qualifier": "involved_in", "term": "myotube differentiation involved in skeletal muscle regeneration"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0017015", "pubmed": 19328798, "qualifier": "NOT involved_in", "term": "regulation of transforming growth factor beta receptor signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035019", "qualifier": "involved_in", "term": "somatic stem cell population maintenance"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035914", "qualifier": "involved_in", "term": "skeletal muscle cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045445", "qualifier": "involved_in", "term": "myoblast differentiation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0045944", "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0060070", "qualifier": "involved_in", "term": "canonical Wnt signaling pathway"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005801", "pubmed": 23386608, "qualifier": "located_in", "term": "cis-Golgi network"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0016528", "qualifier": "located_in", "term": "sarcoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:1990907", "qualifier": "part_of", "term": "beta-catenin-TCF complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:1990907", "pubmed": 28296634, "qualifier": "part_of", "term": "beta-catenin-TCF complex"}, {"evidence": "IPI", "gocategory": "CC", "id": "GO:1990907", "pubmed": 11955446, "qualifier": "part_of", "term": "beta-catenin-TCF complex"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0003713", "qualifier": "enables", "term": "transcription coactivator activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [11955446, 16630820, 17052462, 17113272, 18498752, 21399610, 24981860], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0008013", "qualifier": "enables", "term": "beta-catenin binding"}]}, "homologene": {"genes": [[7955, 449616], [8364, 100489374], [9031, 418456], [9544, 700800], [9598, 457248], [9606, 607], [9615, 483154], [9913, 788729], [10090, 77578], [10116, 310704]], "id": 3191}, "interpro": [{"desc": "Zinc finger, RING/FYVE/PHD-type", "id": "IPR013083", "short_desc": "Znf_RING/FYVE/PHD"}, {"desc": "B Cell Lymphoma 9", "id": "IPR015668", "short_desc": "Bcl-9/Bcl-9l"}, {"desc": "B-cell lymphoma 9, beta-catenin binding domain", "id": "IPR024670", "short_desc": "BCL9_beta-catenin-bd_dom"}], "ipi": "IPI00160290", "map_location": "1q21.2", "name": "BCL9 transcription coactivator", "other_names": ["B cell CLL/lymphoma 9", "B-cell CLL/lymphoma 9 protein", "B-cell lymphoma 9 protein", "bcl-9", "protein legless homolog"], "pantherdb": {"HGNC": "1008", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1924828", "ortholog_type": "LDO", "panther_family": "PTHR15185", "taxid": 10090, "uniprot_kb": "Q9D219"}, {"RGD": "1306934", "ortholog_type": "LDO", "panther_family": "PTHR15185", "taxid": 10116, "uniprot_kb": "D4A7D6"}, {"Ensembl": "ENSGALG00000037655", "ortholog_type": "LDO", "panther_family": "PTHR15185", "taxid": 9031, "uniprot_kb": "A0A1D5PQ44"}, {"ZFIN": "ZDB-GENE-090313-135", "ortholog_type": "LDO", "panther_family": "PTHR15185", "taxid": 7955, "uniprot_kb": "F1R405"}], "uniprot_kb": "O00512"}, "pathway": {"netpath": {"id": "Pathway_Wnt", "name": "Wnt"}, "pid": {"id": "betacatenin_nuc_pathway", "name": "Regulation of nuclear beta catenin signaling and target gene transcription"}, "reactome": [{"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-195721", "name": "Signaling by WNT"}, {"id": "R-HSA-201681", "name": "TCF dependent signaling in response to WNT"}, {"id": "R-HSA-201722", "name": "Formation of the beta-catenin:TCF transactivating complex"}, {"id": "R-HSA-3769402", "name": "Deactivation of the beta-catenin transactivating complex"}], "wikipathways": [{"id": "WP363", "name": "Wnt Signaling Pathway"}, {"id": "WP3658", "name": "Wnt-beta-catenin signaling pathway in leukemia"}, {"id": "WP4905", "name": "1q21.1 copy number variation syndrome"}]}, "pdb": ["2GL7", "2VP7", "2VPB", "2VPD", "2VPE", "2VPG", "3SL9", "8Y0P"], "pfam": "PF11502", "pharmgkb": "PA25318", "pharos": {"target_id": 15814, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF218315", "relationship": "is"}, {"id": "GNF246307", "relationship": "is"}, {"id": "GNF246308", "relationship": "is"}, {"id": "GNF246309", "relationship": "is"}, {"id": "GNF246310", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF279729", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF099302", "relationship": "is"}, {"id": "GNF138957", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1"], "protein": "NP_004317.2", "rna": "NM_004326.4", "translation": {"protein": "NP_004317.2", "rna": "NM_004326.4"}}, "reporter": {"HG-U133_Plus_2": "204129_at", "HG-U95Av2": "361_at", "HTA-2_0": "TC01001113.hg.1", "HuEx-1_0": "2356818", "HuGene-1_1": "7904907", "HuGene-2_1": "16670114"}, "summary": "BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. [provided by RefSeq, Jul 2008].", "symbol": "BCL9", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1332402"}, "unigene": "Hs.415209", "uniprot": {"Swiss-Prot": "O00512", "TrEMBL": ["A0A804HIV1", "Q1JQ81", "A0A804HI55"]}, "wikipedia": {"url_stub": "BCL9"}}